Choline bitartrate is a salt form of choline — an essential nutrient and the simplest choline supplement available. Choline is a water-soluble quaternary ammonium compound that is technically neither a vitamin nor a mineral but is grouped with the B vitamins due to its importance in similar metabolic roles. It serves as a precursor for acetylcholine (the primary neurotransmitter of learning and memory), as a methyl group donor via betaine in the methionine cycle, and as a structural component of phosphatidylcholine, the dominant phospholipid in cell membranes.
Choline bitartrate is formed by combining choline with tartaric acid to create a stable, highly water-soluble salt that is easy to manufacture and inexpensive. As a supplement, it is the most economical way to supplement choline. However, it has a significant limitation compared to more sophisticated choline sources: only a fraction of oral choline bitartrate reaches the brain. This is because free choline has limited transport across the blood-brain barrier compared to phospholipid-bound forms such as Alpha-GPC or citicoline. As a result, choline bitartrate is most effective for ensuring adequate systemic choline status (liver function, lipid transport, methylation), but less effective for directly boosting brain acetylcholine levels.
Community experience with choline bitartrate as a nootropic is decidedly mixed. Many users find it functional for preventing the "racetam headache" at moderate doses, while others report it is less effective than Alpha-GPC or citicoline for the same purpose. High doses can produce significant side effects including body odor (the "fishy smell" caused by choline conversion to trimethylamine in the gut), nausea, and a distinctly uncomfortable mental heaviness that choline-sensitive individuals associate with excess ACh activity. Despite its limitations relative to premium choline sources, choline bitartrate remains a staple because of its low cost and widespread availability.
Safety at a Glance
High Risk- Understanding Limitations
- Nutritional supplement range: 500–1,000 mg/day
- Toxicity: Safety Profile Choline is an essential nutrient and choline bitartrate is generally regarded as safe at nutritional d...
- Overdose risk: Limited specific overdose data is available for Choline bitartrate. In the absence of compound-sp...
If someone is in crisis, call 911 or Poison Control: 1-800-222-1222
Dosage
oral
Duration
oral
Total: 4 hrs – 8 hrsHow It Feels
Choline bitartrate is perhaps the most invisible of all supplements that people nonetheless continue to take. Within an hour of oral ingestion, the honest assessment for most users is that nothing has happened. There is no perceptible shift in mood, attention, energy, or any other axis of subjective experience. The compound has been absorbed, it is doing its biochemical work as a choline donor, and the conscious mind has received no memo about any of it.
With sustained use over days to weeks, and particularly when combined with racetam-class nootropics that increase acetylcholine demand, some users report a very mild improvement in baseline cognitive clarity. Thoughts may arrive with fractionally more precision. Memory encoding may be marginally improved. But these effects are so subtle and so deeply embedded in the noise of daily cognitive variation that attributing them confidently to choline supplementation requires a degree of self-awareness that borders on the unrealistic.
The primary subjective experience of choline bitartrate, when there is one, is unfortunately more likely to be negative than positive. Fishy body odor and breath are common at higher doses, a consequence of trimethylamine production during metabolism. Gastrointestinal discomfort, including nausea, cramping, and diarrhea, can occur. Some users report a depressive or flat quality to mood, potentially related to excessive cholinergic tone. These side effects, modest though they are, often constitute the most noticeable aspect of the choline bitartrate experience.
The compound has no duration in the traditional sense because it has no perceptible onset or offset. It is a nutritional substrate, not a drug experience. Its value lies entirely in its biochemical role as a choline source, supporting cell membrane synthesis and acetylcholine production in ways that may improve cognitive function through mechanisms far below the threshold of conscious experience. Taking choline bitartrate is an act of faith in biochemistry, a bet that doing something right for the brain's chemistry will eventually manifest as something felt in the mind.
Subjective Effects
The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.
Physical Effects
Physical(6)
- Body odour alteration— Body odour alteration is a distinct change in a person's natural scent that can occur when the body ...
- Diarrhea— Diarrhea is the occurrence of frequent, loose, or watery bowel movements as a side effect of certain...
- Dizziness— A sensation of spinning, swaying, or lightheadedness that impairs balance and spatial orientation, o...
- Headache— A painful sensation of pressure, throbbing, or aching in the head that can range from a dull backgro...
- Nausea— An uncomfortable sensation of queasiness and stomach discomfort that may or may not lead to vomiting...
- Stimulation— A state of heightened physical and mental energy characterized by increased wakefulness, elevated mo...
Pharmacology
Mechanism of Action
Choline bitartrate dissociates in the GI tract to free choline and bitartrate ion. Free choline is absorbed in the small intestine via active transport and enters systemic circulation, where it is distributed to all tissues. Choline has three primary metabolic roles:
Acetylcholine Synthesis
Choline is taken up into neurons via the high-affinity choline transporter (CHT1) and converted to acetylcholine by choline acetyltransferase (ChAT) in cholinergic neurons. Acetylcholine acts at nicotinic and muscarinic receptors throughout the brain, modulating attention, learning, memory, and arousal via the basal forebrain cholinergic system and its projections to cortex and hippocampus.
Phospholipid Synthesis
Choline contributes to the CDP-choline pathway (Kennedy pathway), ultimately yielding phosphatidylcholine for cell membranes. This structural role is important for membrane fluidity and cellular signaling.
Methyl Group Donation
Choline can be oxidized to betaine, which serves as a methyl donor in the remethylation of homocysteine to methionine. This positions choline as part of the one-carbon metabolism cycle that includes folate and B12.
Blood-Brain Barrier Transport
A key limitation of choline bitartrate is that free choline crosses the blood-brain barrier inefficiently via a low-affinity transport system that saturates at plasma concentrations achievable with typical supplemental doses. In contrast, Alpha-GPC and citicoline deliver choline in phospholipid-bound forms with more efficient CNS delivery. This is the primary pharmacological reason why Alpha-GPC and citicoline are preferred for cognitive applications despite their higher cost.
Pharmacokinetics
Choline is rapidly absorbed following oral ingestion, with peak plasma concentrations in 1–2 hours. Elimination is via urinary excretion and metabolic conversion to betaine. Intestinal bacteria can metabolize choline to trimethylamine (TMA), which is then absorbed and oxidized to TMAO in the liver — this pathway is responsible for the fishy body odor some users experience and has been associated with cardiovascular risk in epidemiological studies.
Interactions
No documented interactions.
History
Choline as an Essential Nutrient
Choline was first described as a chemical in the mid-19th century. Its biological importance was recognized through the discovery that lecithin (phosphatidylcholine) was essential for normal liver function. In 1998, the US Institute of Medicine formally classified choline as an essential nutrient and established Adequate Intake (AI) and Tolerable Upper Intake Level (UL) values, acknowledging that most humans do not achieve optimal choline intake from diet alone — especially women of childbearing age, vegetarians, and those with certain genetic variants affecting choline metabolism (particularly PEMT variants).
Supplement Development
Choline bitartrate as a specific salt form was developed as a stable, water-soluble formulation for supplemental and pharmaceutical use. It became commercially available as a dietary supplement in the mid-20th century. Its low manufacturing cost and chemical stability made it the default choice for choline supplementation in early dietary supplement products.
The Nootropic Era
With the rise of racetam nootropics in the 1980s and 1990s, choline bitartrate became a standard co-supplement because the prevailing theory held that racetams increased acetylcholine utilization and required supplemental choline to prevent depletion headaches. As the nootropic market matured and more bioavailable alternatives (citicoline, Alpha-GPC) became available and commercially viable, choline bitartrate's position as the go-to choline supplement for cognitive purposes was partially displaced, though it remains popular due to its cost advantage.
Harm Reduction
Understanding Limitations
Choline bitartrate is the most economical choline source but has inferior CNS bioavailability compared to Alpha-GPC and citicoline. If you are supplementing choline specifically to support brain acetylcholine (e.g., when stacking with racetams, or targeting cognitive function), Alpha-GPC or citicoline will generally provide a more reliable and dose-efficient result.
Dosing
- Nutritional supplement range: 500–1,000 mg/day
- When stacking with racetams: 500–1,500 mg; adjust based on headache response
- The "choline headache" from racetam use (frontal, dull) typically responds to 500–1,000 mg choline bitartrate, though some users find this dose insufficient and switch to Alpha-GPC
Body Odor Warning
Some individuals produce significant trimethylamine (TMA) from choline bitartrate via gut bacterial metabolism. This produces a distinctly fishy or metabolic body odor that is immediately noticeable to others. If you notice this effect, it will not resolve by continuing the supplement — either reduce the dose or switch to a different choline form (Alpha-GPC produces less TMA).
Taking with Food
Taking choline bitartrate with food reduces GI side effects significantly. It is not fat-soluble (unlike aniracetam), so fat co-administration is not required, but food helps with tolerability.
When to Upgrade
If you are primarily using choline bitartrate for the choline component of a nootropic stack, consider whether the cost difference to Alpha-GPC or citicoline is meaningful for your budget. The per-serving price difference is often small when comparing equivalent choline content, and the improved brain bioavailability is generally worth it for cognitive applications.
Toxicity & Safety
Safety Profile
Choline is an essential nutrient and choline bitartrate is generally regarded as safe at nutritional doses. The Tolerable Upper Intake Level (UL) established by the US Institute of Medicine is 3.5 g/day for adults, above which cholinergic side effects become likely.
Common Side Effects
At typical supplemental doses (500–1,000 mg/day):
- Nausea, particularly on an empty stomach
- GI discomfort
- Sweating with a fishy or "metabolic" odor (due to TMA production by gut bacteria)
At higher doses or in sensitive individuals:
- Strong body odor (trimethylaminuria-like syndrome)
- Profuse sweating
- Low blood pressure and dizziness
- Pronounced mental fatigue and low mood ("choline heaviness")
- Salivation, lacrimation, urinary urgency (signs of cholinergic excess at very high doses)
Cardiovascular Considerations
The conversion of choline to TMAO (trimethylamine N-oxide) via gut bacteria has been associated with increased atherosclerosis risk in epidemiological studies. The clinical significance of TMAO elevation from choline supplementation (as distinct from dietary choline from red meat) is uncertain and actively debated. Those with existing cardiovascular risk may wish to prefer citicoline or Alpha-GPC, which may have a more favorable TMAO profile.
Drug Interactions
- Anticholinergic drugs: direct pharmacological antagonism
- Cholinesterase inhibitors (donepezil, rivastigmine): additive cholinergic stimulation
Addiction Potential
not habit-forming
Overdose Information
Limited specific overdose data is available for Choline bitartrate. In the absence of compound-specific information, general principles apply:
If someone exhibits signs of medical distress after using Choline bitartrate — difficulty breathing, severe confusion, seizures, chest pain, extremely elevated temperature, or loss of consciousness — treat it as a medical emergency. Call emergency services and be forthcoming about what was consumed. Medical professionals follow confidentiality protocols and their priority is saving lives.
Prevention remains the best approach: use the minimum effective dose, avoid combining with other substances, and always have a sober person present who can recognize signs of distress and call for help.
Tolerance
| Full | after prolonged and repeated usage |
| Half | 7 days |
| Zero | 14 days |
Cross-tolerances
Legal Status
Germany: Choline bitartrate is an approved dietary supplement.
United States: In the United States, choline is legal as a dietary supplement. The Food and Drug Administration (FDA) requires choline to be in non-dairy infant formula.
Choline (Wikipedia)
Abbott, A. P., Capper, G., Davies, D. L., Rasheed, R. K., & Tambyrajah, V. (2003). Novel solvent properties of choline chloride/urea mixtures. Chemical Communications, 99(1), 70–71. https://doi.org/10.1039/b210714g
Behari, J., Yeh, T.-H., Krauland, L., Otruba, W., Cieply, B., Hauth, B., … Monga, S. P. S. (2010). Liver-Specific B-Catenin Knockout Mice Exhibit Defective Bile Acid and Cholesterol Homeostasis and Increased Susceptibility to Diet-Induced Steatohepatitis. The American Journal of Pathology, 176(2), 744–753. https://doi.org/10.2353/ajpath.2010.090667
Chan, K. C., So, K. fai, & Wu, E. X. (2009). Proton magnetic resonance spectroscopy revealed choline reduction in the visual cortex in an experimental model of chronic glaucoma. Experimental Eye Research, 88(1), 65–70. https://doi.org/10.1016/j.exer.2008.10.002
Doggrell, S. a, & Evans, S. (2003). Treatment of dementia with neurotransmission modulation. Expert Opinion on Investigational Drugs, 12(10), 1633–54. https://doi.org/10.1517/13543784.12.10.1633
Glier, M. B., Green, T. J., & Devlin, A. M. (2014). Methyl nutrients, DNA methylation, and cardiovascular disease. Molecular Nutrition and Food Research, 58(1), 172–182. https://doi.org/10.1002/mnfr.201200636
Klatskin, G. (1954). the Effect of Alcohol on the Choline Requirement: Ii. Incidence of Renal Necrosis in Weanling Rats Following Short Term Ingestion of Alcohol. Journal of Experimental Medicine, 100(6), 615–627. https://doi.org/10.1084/jem.100.6.615
Nery, F. G., Stanley, J. A., Chen, H.-H., Hatch, J. P., Nicoletti, M. A., Serap Monkul, E., … Soares, J. C. (2010). Bipolar disorder comorbid with alcoholism: A 1H magnetic resonance spectroscopy study. Journal of Psychiatric Research, 44(5), 278–285. https://doi.org/10.1016/j.jpsychires.2009.09.006
Parnetti, L., Mignini, F., Tomassoni, D., Traini, E., & Amenta, F. (2007). Cholinergic precursors in the treatment of cognitive impairment of vascular origin: Ineffective approaches or need for re-evaluation? Journal of the Neurological Sciences, 257(1–2), 264–269. https://doi.org/10.1016/j.jns.2007.01.043
Stoll, A. L., Sachs, G. S., Cohen, B. M., Lafer, B., Christensen, J. D., & Renshaw, P. F. (1996). Choline in the treatment of rapid-cycling bipolar disorder: Clinical and neurochemical findings in lithium-treated patients. Biological Psychiatry, 40(5), 382–388. https://doi.org/10.1016/0006-3223(95)00423-8
Tolvanen, T., Yli-Kerttula, T., Ujula, T., Autio, A., Lehikoinen, P., Minn, H., & Roivainen, A. (2010). Biodistribution and radiation dosimetry of [11C]choline: A comparison between rat and human data. European Journal of Nuclear Medicine and Molecular Imaging, 37(5), 874–883. https://doi.org/10.1007/s00259-009-1346-z
Van Beek, A. H. E. A., & Claassen, J. A. H. R. (2011). The cerebrovascular role of the cholinergic neural system in Alzheimer’s disease. Behavioural Brain Research, 221(2), 537–542. https://doi.org/10.1016/j.bbr.2009.12.047
Zeisel, S. H., & Da Costa, K. A. (2009). Choline: An essential nutrient for public health. Nutrition Reviews, 67(11), 615–623. https://doi.org/10.1111/j.1753-4887.2009.00246.x
Experience Reports (1)
Tips (2)
Keep a journal when starting Choline bitartrate to track cognitive effects, mood, sleep quality, and side effects. Nootropic effects are often subtle, and subjective tracking helps determine if a substance is genuinely beneficial for you.
Purchase Choline bitartrate from reputable vendors who provide third-party certificates of analysis (COA). Nootropic quality varies enormously between suppliers, and contamination or mislabeling is common in unregulated markets.
See Also
References (3)
- PubChem: Choline bitartrate
PubChem compound page for Choline bitartrate (CID: 6900)
pubchem - Choline bitartrate - TripSit Factsheet
TripSit factsheet for Choline bitartrate
tripsit - Choline bitartrate - Wikipedia
Wikipedia article on Choline bitartrate
wikipedia